Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 366, Pages 366ra162-366ra162
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-11-24
DOI
10.1126/scitranslmed.aaf8463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The microglial ATP-gated ion channel P2X7 as a CNS drug target
- (2016) Anindya Bhattacharya et al. GLIA
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
- (2015) Ben J. Gu et al. HUMAN MOLECULAR GENETICS
- The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
- (2015) Maarten Van Roy et al. ARTHRITIS RESEARCH & THERAPY
- A novel platform for engineering blood-brain barrier-crossing bispecific biologics
- (2014) Graham K. Farrington et al. FASEB JOURNAL
- A Novel Flow Cytometric Method To Assess Inflammasome Formation
- (2014) David P. Sester et al. JOURNAL OF IMMUNOLOGY
- Nucleotide signalling during inflammation
- (2014) Marco Idzko et al. NATURE
- The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
- (2014) Alberto Baroja-Mazo et al. NATURE IMMUNOLOGY
- Antibody therapeutics targeting ion channels: are we there yet?
- (2013) Han Sun et al. ACTA PHARMACOLOGICA SINICA
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Technical Advance: A new cell preparation strategy that greatly improves the yield of vital and functional Tregs and NKT cells
- (2013) Björn Rissiek et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical evaluation of the efficacy of the P2X7purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine
- (2012) Edward C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
- (2012) W Nörenberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging
- (2012) Tengfei Li et al. FASEB JOURNAL
- Efficacy and Safety of CE-224,535, an Antagonist of P2X7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
- (2012) T. C. STOCK et al. JOURNAL OF RHEUMATOLOGY
- Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity
- (2012) Robert E Sorge et al. NATURE MEDICINE
- Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
- (2012) Yosuke Kurashima et al. Nature Communications
- Gain-of-function of P2X7 receptor gene variants in multiple sclerosis
- (2011) Olatz Oyanguren-Desez et al. CELL CALCIUM
- A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
- (2011) Nishkantha Arulkumaran et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nephrotic Syndrome and Subepithelial Deposits in a Mouse Model of Immune-Mediated Anti-Podocyte Glomerulonephritis
- (2011) C. Meyer-Schwesinger et al. JOURNAL OF IMMUNOLOGY
- Lack of the purinergic receptor P2X7results in resistance to contact hypersensitivity
- (2010) Felix C. Weber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NAD+ and ATP Released from Injured Cells Induce P2X7-Dependent Shedding of CD62L and Externalization of Phosphatidylserine by Murine T Cells
- (2009) F. Scheuplein et al. JOURNAL OF IMMUNOLOGY
- Antagonists of the P2X7Receptor. From Lead Identification to Drug Development
- (2009) Simon D. Guile et al. JOURNAL OF MEDICINAL CHEMISTRY
- P2X7 Deficiency Attenuates Renal Injury in Experimental Glomerulonephritis
- (2009) S. R.J. Taylor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
- (2009) Janusz Wesolowski et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Genetics of the P2X7 receptor and human disease
- (2009) Stephen J. Fuller et al. Purinergic Signalling
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- Transient expression and purification of chimeric heavy chain antibodies
- (2008) Jianbing Zhang et al. PROTEIN EXPRESSION AND PURIFICATION
- Selective P2X7 receptor antagonists for chronic inflammation and pain
- (2008) William A. Carroll et al. Purinergic Signalling
- ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site
- (2007) Sahil Adriouch et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation